VANCOUVER, BC and HOUSTON, TX / ACCESSWIRE / May 16, 2024 / Bio Conscious Technologies Inc., a global leader at the intersection of Artificial Intelligence (AI) and Health Technology today announced a ...
Bristol Myers Squibb, GSK and Merck are contributing drug ingredients as part of their deals with the White House but are keeping many of the terms of their agreements private.
GUANGHAN, CHINA / ACCESSWIRE / August 20, 2021 / On April 27, Zhang Ge, Board Chairman and President of Sichuan Deebio Pharmaceutical Co., Ltd. (hereinafter referred to as Deebio), participated in the ...
Ajinomoto Bio-Pharma Services is taking full control of an API manufacturing facility in India as the CDMO continues to bulk up in a market that favors companies that can do it all. Ajinomoto ...
API-192 is a first-in-class off-the-shelf allogeneic CAR-NKT cell therapy that expresses dual CARs targeting CD19 and CD20 and armored with soluble IL-15 for improved expansion and persistence API-192 ...
Sharon Bio-Medicine today said it has received approval from the US health regulator for its API plant at Taloja in Maharashtra. The company, however, said it cannot start supplying to the US market ...
Endobits Automated Remote Patient Management Platform Will Now Deploy Its Industry-Leading AI-Powered Software to Securely Integrate Dexcom CGM Data VANCOUVER, BC and HOUSTON, TX / ACCESSWIRE / May 16 ...
Sharon Bio-Medicine today said it has received approval from the US health regulator for its API plant at Taloja in Maharashtra. The company, however, said it cannot start supplying to the US market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results